We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
-12.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12.1B
AUM Growth
-$2.55B
(-17%)
Cap. Flow
-$469M
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
25.18%
Holding
858
New
52
Increased
315
Reduced
272
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$38.7M |
| 2 |
Apple
AAPL
|
+$27.7M |
| 3 |
Salesforce
CRM
|
+$26.1M |
| 4 |
Verizon
VZ
|
+$25.9M |
| 5 |
PepsiCo
PEP
|
+$24.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.7M |
| 2 |
Waste Management
WM
|
+$64.8M |
| 3 |
Sociedad Química y Minera de Chile
SQM
|
+$58.6M |
| 4 |
Citigroup
C
|
+$56.5M |
| 5 |
Johnson & Johnson
JNJ
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.24% |
| 2 | Technology | 24.24% |
| 3 | Financials | 8.36% |
| 4 | Communication Services | 6.82% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Mastercard
MA
$477B
| $56.7M | 0.47% |
179,794
+5,157
| +3% | +$1.78M |
|
52
McDonald's
MCD
$188B
| $56.6M | 0.47% |
229,097
-47,019
| -17% | -$11.6M |
|
53
Incyte
INCY
$23.5B
| $56.2M | 0.46% |
740,202
-11,557
| -2% | -$878K |
|
54
Owens Corning
OC
$11.5B
| $55.8M | 0.46% |
750,405
+3,164
| +0.4% | +$279K |
|
55
Emerson Electric
EMR
$82.9B
| $53.3M | 0.44% |
670,303
-277,732
| -29% | -$24.5M |
|
56
CVS Health
CVS
$137B
| $53.2M | 0.44% |
574,174
+112,887
| +24% | +$11M |
|
57
Biogen
BIIB
$29.9B
| $51.4M | 0.42% |
252,193
+9,133
| +4% | +$1.87M |
|
|
58
PepsiCo
PEP
$186B
| $50.9M | 0.42% |
305,247
+143,214
| +88% | +$24.1M |
|
59
AbbVie
ABBV
$458B
| $50.8M | 0.42% |
331,801
-28,037
| -8% | -$4.28M |
|
60
Alnylam Pharmaceuticals
ALNY
$36.3B
| $50.1M | 0.41% |
343,213
+39,560
| +13% | +$5.61M |
|
|
61
Verizon
VZ
$194B
| $46.3M | 0.38% |
913,042
+512,291
| +128% | +$25.9M |
|
62
PayPal
PYPL
$49.5B
| $45.1M | 0.37% |
646,234
-101,642
| -14% | -$8.82M |
|
63
American Water Works
AWK
$26.3B
| $45.1M | 0.37% |
303,079
-24,983
| -8% | -$3.81M |
|
64
Applied Materials
AMAT
$426B
| $43.8M | 0.36% |
481,644
-69,228
| -13% | -$7.59M |
|
65
JPMorgan Chase
JPM
$939B
| $43.5M | 0.36% |
386,335
+126,663
| +49% | +$15.7M |
|
66
TSMC
TSM
$2.09T
| $43.2M | 0.36% |
529,050
-156,230
| -23% | -$14.4M |
|
67
Equinix
EQIX
$107B
| $42.6M | 0.35% |
64,900
+7,531
| +13% | +$5.22M |
|
68
AstraZeneca
AZN
$263B
| $42.6M | 0.35% |
322,066
-116,864
| -27% | -$15.3M |
|
69
Synopsys
SNPS
$71.5B
| $42.4M | 0.35% |
139,744
+15,834
| +13% | +$4.78M |
|
70
Ball Corp
BALL
$17B
| $42M | 0.35% |
611,211
+101,052
| +20% | +$7.67M |
|
71
Morgan Stanley
MS
$337B
| $41.7M | 0.34% |
548,850
+888
| +0.2% | +$72.7K |
|
72
Illumina
ILMN
$29.4B
| $41.7M | 0.34% |
232,707
-2,574
| -1% | -$657K |
|
73
Pfizer
PFE
$140B
| $41.5M | 0.34% |
791,450
+382,709
| +94% | +$19.5M |
|
74
Prologis
PLD
$138B
| $40.1M | 0.33% |
341,190
+25,071
| +8% | +$3.47M |
|
|
MRTX
75
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $39.9M | 0.33% |
594,284
+87,511
| +17% | +$5.57M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2022 Portfolio in Review
As of Q2 2022, Candriam SCA held 858 positions worth $12.1B, down 17% from $14.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Candriam SCA withdrew a net $469M in Q2 2022, closing 83 positions and reducing 272 holdings. Its most notable exit was TriState Capital Holdings, Inc., an estimated $20.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Technology and Financials.
Against the trend, Candriam SCA opened a new position in Tenable Holdings worth $16.3M.
- Candriam SCA's largest Q2 2022 buy was Tenable Holdings: 359,981 shares worth $16.3M.
- Candriam SCA added most to Procter & Gamble in Q2 2022, an estimated $38.7M increase.
- Candriam SCA's biggest Q2 2022 reduction was Microsoft, cutting an estimated $65.7M.
- Candriam SCA fully exited TriState Capital Holdings, Inc. in Q2 2022, selling an estimated $20.9M.
- Candriam SCA's ten largest holdings make up 25% of its $12.1B portfolio in Q2 2022.
- Candriam SCA opened 52 new positions and closed 83 in Q2 2022.
- Candriam SCA's portfolio value fell 17% quarter-over-quarter to $12.1B.
Based on Candriam SCA's 13F filing for Q2 2022, filed 3 Aug 2022.